|Day Low/High||8.40 / 9.35|
|52 Wk Low/High||5.50 / 17.49|
There are any number of ways the inconsistency in the market action can fix itself.
I'm becoming more confident that small-caps have bottomed heading into earnings.
One group acting better is the MSO (multi-state operator) pot names.
The cannabis sector is finally turning back up after a sharp correction that started in early February.
Leading advisors offer their favorite ideas for investors looking for exposure to the growing marijuana market.
The main names that I'm focused on are leveraged to growth in the U.S.
The best momentum on my screens right now are the U.S. cannabis plays that are referred to as Multi-State Operators.
The data estimates that the U.S. cannabis market will reach $28 billion in sales by 2022.
No one likes seeing a name they hold decline in value.
New York became the 16th state to legalize adult use cannabis.
So far today, aggressive stock picking is looking like a possibility.
We are seeing better trading action as the day continues, and I'm looking to put more cash to work.
Much of the cannabis money is rotating back into bitcoin plays.
This signals a big step for Akerna -- and the stock.
The main themes are bitcoin, cannabis, stocks priced under $10, small biotechnology, and small-caps in general.
There are much better places an investor can put their hard-earned cash, whether they want an aggressive or a moderate name.
Study those charts and be ready to act as things develop.
Even the solid gains on the major indexes fail to show just how good individual stock picking can be right now.
My favorite group at the moment is cannabis.
Georgia's election results have given the industry a big green light, meaning positive moves are expected out of cannabis stocks.
I'm focused on stock picking and continue to hunt for more sector plays.
Two more major deals were announced on Tuesday.
I am watching names like Curaleaf and the MSOS cannabis ETF, which could keep moving higher.
This is the first time that any cannabis bill addressing descheduling has been approved by Congress.